Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma

(2013) M. P. Purdue et al.   BLOOD

Markers of B-Cell Activation in Relation to Risk of Non-Hodgkin Lymphoma

(2012) A. J. De Roos et al.   CANCER RESEARCH

Circulating Soluble CD30 and Future Risk of Lymphoma; Evidence from Two Prospective Studies in the General Population

(2011) R. Vermeulen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prediagnostic Serum Levels of Cytokines and Other Immune Markers and Risk of Non-Hodgkin Lymphoma

(2011) M. P. Purdue et al.   CANCER RESEARCH

Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study

(2010) Yian Gu et al.   CANCER CAUSES & CONTROL

Assessment of Pre-Diagnosis Biomarkers of Immune Activation and Inflammation: Insights on the Etiology of Lymphoma

(2010) Elena Vendrame et al.   JOURNAL OF PROTEOME RESEARCH

A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma

(2009) M. P. Purdue et al.   BLOOD